Benzinga | Nov 5, 2021 09:22AM EDT

Assertio Therapeutics Q3 EPS $0.08 Beats $(0.04) Estimate, Sales $25.47M Beat $22.04M Estimate

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.04) by 300 percent. This is a 122.22 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $25.47 million which beat the analyst consensus estimate of $22.04 million by 15.56 percent. This is a 26.31 percent decrease over sales of $34.56 million the same period last year.